With regard to NSCLC pathogenesis, increased expression of the anti-apoptotic protein Bcl-2 and reduced levels of the pro-apoptotic protein Bax have been reported to be correlated with chemoresistance and tumour development [13, 14]. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.